newsfilter
← Latest News
PR Newswire·

Movano Health Plans Response Submission to FDA Next Week as Part of EvieMED Final Review Phase

Movano Health (Nasdaq: MOVE) announced today that it plans to submit updated responses next week to all clarifying questions that it recently...